Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis
Clinical trial NCT03915496 · COMPLETED
Trial details
- NCT number
- NCT03915496
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-18
- Primary completion
- 2021-11-16
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.